Performance Health Systems UK Ltd 08102963 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is sale and distribution of advanced health and wellness technologies. Digita Accounts Production Advanced 6.30.9574.0 true true 08102963 2024-01-01 2024-12-31 08102963 2024-12-31 08102963 bus:Director1 2024-12-31 08102963 bus:Director3 2024-12-31 08102963 core:RetainedEarningsAccumulatedLosses 2024-12-31 08102963 core:ShareCapital 2024-12-31 08102963 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08102963 core:FurnitureFittings 2024-12-31 08102963 core:OfficeEquipment 2024-12-31 08102963 core:PlantMachinery 2024-12-31 08102963 bus:SmallEntities 2024-01-01 2024-12-31 08102963 bus:Audited 2024-01-01 2024-12-31 08102963 bus:FullAccounts 2024-01-01 2024-12-31 08102963 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08102963 bus:RegisteredOffice 2024-01-01 2024-12-31 08102963 bus:Director1 2024-01-01 2024-12-31 08102963 bus:Director3 2024-01-01 2024-12-31 08102963 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08102963 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 08102963 core:ShareCapital 2024-01-01 2024-12-31 08102963 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 08102963 core:ComputerEquipment 2024-01-01 2024-12-31 08102963 core:FurnitureFittings 2024-01-01 2024-12-31 08102963 core:LeaseholdImprovements 2024-01-01 2024-12-31 08102963 core:OfficeEquipment 2024-01-01 2024-12-31 08102963 core:PlantMachinery 2024-01-01 2024-12-31 08102963 countries:AllCountries 2024-01-01 2024-12-31 08102963 2023-12-31 08102963 core:RetainedEarningsAccumulatedLosses 2023-12-31 08102963 core:ShareCapital 2023-12-31 08102963 core:FurnitureFittings 2023-12-31 08102963 core:OfficeEquipment 2023-12-31 08102963 core:PlantMachinery 2023-12-31 08102963 2023-01-01 2023-12-31 08102963 2023-12-31 08102963 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 08102963 core:FurnitureFittings 2023-12-31 08102963 core:OfficeEquipment 2023-12-31 08102963 core:PlantMachinery 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 08102963

Performance Health Systems UK Ltd

Annual Report and Financial Statements

for the Year Ended 31 December 2024

 

Performance Health Systems UK Ltd

Contents

Company Information

1

Director's Report

2

Statement of Director's Responsibilities

3

Independent Auditor's Report

4 to 6

Profit and Loss Account

7

Balance Sheet

8

Statement of Changes in Equity

9

Notes to the Financial Statements

10 to 15

 

Performance Health Systems UK Ltd

Company Information

Director:

I Murray

Registered office:

20 Wenlock Road,
London,
England,
N1 7GU

Registered number:

08102963

Auditors:

Wem & Co
Chartered Accountants & Statutory Auditors
Savoy House
Savoy Circus
London
W3 7DA

 

Performance Health Systems UK Ltd

Director's Report for the Year Ended 31 December 2024

The director presents his report and the financial statements for the year ended 31 December 2024.

Principal activity

The principal activity of the company is sale and distribution of advanced health and wellness technologies.

Director of the company

The director who held office during the year was as follows:

Stephen Anthony Wright (ceased 29 April 2025)

The following director was appointed after the year end:

I Murray (appointed 1 April 2025)

Disclosure of information to the auditors

The director has taken steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information. The director confirms that there is no relevant information that he knows of and of which he knows the auditors are unaware.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 25 September 2025
 

.........................................
I Murray
Director

.........................................
I Murray
Director

 

Performance Health Systems UK Ltd

Statement of Director's Responsibilities

The director acknowledges his responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Performance Health Systems UK Ltd

Independent Auditor's Report to the Members of Performance Health Systems UK Ltd

Opinion

We have audited the financial statements of Performance Health Systems UK Ltd (the 'company') for the year ended 31 December 2024, which comprise the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Director's Report has been prepared in accordance with applicable legal requirements.

 

Performance Health Systems UK Ltd

Independent Auditor's Report to the Members of Performance Health Systems UK Ltd (continued)

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Director's Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of director's remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit; or

the director was not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies’ exemptions in preparing the directors’ report and from the requirement to prepare a strategic report.

Responsibilities of the director

As explained more fully in the Statement of Director's Responsibilities [set out on page 3], the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
• Reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;
• Enquiring of management concerning actual and potential litigation and claims; - performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;
• Reading minutes of meetings of those charged with governance;
• Obtained an understanding of provisions and held discussions with management to understand the basis of recognition or non-recognition of tax provisions; and]
• In addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.
We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

 

Performance Health Systems UK Ltd

Independent Auditor's Report to the Members of Performance Health Systems UK Ltd (continued)

As part of an audit in accordance with ISAs (UK), we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control.

Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the director.

Conclude on the appropriateness of the director's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.

Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the company to express an opinion on the financial statements. We are responsible for the direction, supervision and performance of the company audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
Shanoor Miah BSc FCA (Senior Statutory Auditor)
For and on behalf of Wem & Co, Statutory Auditor

Savoy House
Savoy Circus
London
W3 7DA

25 September 2025

 

Performance Health Systems UK Ltd

Profit and Loss Account for the Year Ended 31 December 2024

Note

31.12.24

31.12.23

   

£

£

£

£

TURNOVER

   

1,872,734

 

1,965,105

Cost of sales

   

(995,022)

 

(1,194,413)

GROSS PROFIT

   

877,712

 

770,692

Administrative expenses

 

1,504,219

 

1,855,367

 

   

(1,504,219)

 

(1,855,367)

Operating loss

   

(626,507)

 

(1,084,675)

Interest payable and similar expenses

   

(103,333)

 

304,827

Loss before tax

 

(729,840)

 

(779,848)

PROFIT/(LOSS) FOR FINANCIAL YEAR

   

(729,840)

 

(779,848)

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

 

Performance Health Systems UK Ltd

(Registration number: 08102963)
Balance Sheet as at 31 December 2024

Note

31.12.24

31.12.23

   

£

£

£

£

FIXED ASSETS

   

 

Intangible assets

6

 

21,528

 

-

Tangible assets

7

 

2,144

 

1,820

   

23,672

 

1,820

CURRENT ASSETS

   

 

Stocks

8

693,696

 

832,777

 

Debtors

9

285,774

 

315,390

 

Cash at bank and in hand

 

121,400

 

15,979

 

 

1,100,870

 

1,164,146

 

CREDITORS

   

 

Creditors within 1yr

10

7,755,812

 

7,067,396

 

Net current liabilities

   

(6,654,942)

 

(5,903,250)

Total assets less current liabilities

   

(6,631,270)

 

(5,901,430)

PROVISIONS FOR LIABILITIES

 

(64,060)

 

(64,060)

Net liabilities

   

(6,695,330)

 

(5,965,490)

CAPITAL AND RESERVES

   

 

Called up share capital

 

1

 

1

Profit and loss account

 

(6,695,331)

 

(5,965,491)

Shareholders' deficit

   

(6,695,330)

 

(5,965,490)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 25 September 2025

.........................................
I Murray
Director

.........................................
I Murray
Director

 

Performance Health Systems UK Ltd

Statement of Changes in Equity for the Year Ended 31 December 2024

Share capital
£

Profit and loss account
£

Total
£

At 1 January 2023

1

(5,185,643)

(5,185,642)

Changes in equity

Total comprehensive income

-

(779,848)

(779,848)

At 31 December 2023

1

(5,965,491)

(5,965,490)

Share capital
£

Profit and loss account
£

Total
£

At 1 January 2024

1

(5,965,491)

(5,965,490)

Changes in equity

Total comprehensive income

-

(729,840)

(729,840)

At 31 December 2024

1

(6,695,331)

(6,695,330)

 

Performance Health Systems UK Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

1.

General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
20 Wenlock Road,
London,
England,
N1 7GU
United Kingdom

These financial statements were authorised for issue by the director on 25 September 2025.

2.

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentational currency is Pound Sterling (£).

The accounts have been prepared on a going concern basis. In the opinion of the directors the ongoing support provided by the parent company is sufficient to make this basis appropriate

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to
profit and loss.

 

Performance Health Systems UK Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)

2

Accounting policies (continued)

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Improvement to property

Over the lease term, straight line basis

Fixtures and fittings

Straight line over 3 years

Computer equipment

Straight line over 3 years

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Computer software

Over 3 years on straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Performance Health Systems UK Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)

2

Accounting policies (continued)

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Provisions

Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3.

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 13 (2023 - 17).

4.

Auditors' remuneration

31.12.24
£

31.12.23
£

Audit of the financial statements

9,250

9,000


 

5. TAXATION

Tax losses of around £5.18 million are available for offset against future profits.

 

Performance Health Systems UK Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)

6.

Intangible assets

Internally generated software development costs
£

Cost or valuation

At 1 January 2024

82,490

Additions acquired separately

25,000

At 31 December 2024

107,490

Amortisation

At 1 January 2024

82,490

Amortisation charge

3,472

At 31 December 2024

85,962

Carrying amount

At 31 December 2024

21,528

The aggregate amount of research and development expenditure recognised as an expense during the period is £5,030 (2023 - £6,024).
 

 

Performance Health Systems UK Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)

7.

Tangible assets

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Total
£

Cost or valuation

At 1 January 2024

6,371

538

25,499

32,408

Additions

-

-

2,200

2,200

At 31 December 2024

6,371

538

27,699

34,608

Depreciation

At 1 January 2024

6,371

538

23,679

30,588

Charge for the year

-

-

1,876

1,876

At 31 December 2024

6,371

538

25,555

32,464

Carrying amount

At 31 December 2024

-

-

2,144

2,144

At 31 December 2023

-

-

1,820

1,820

8.

Stocks

31.12.24
£

31.12.23
£

Other inventories

693,696

832,777

9.

Debtors

Current

31.12.24
£

31.12.23
£

Trade debtors

213,812

249,301

Prepayments

66,967

38,461

Other debtors

4,995

27,628

 

285,774

315,390

 

Performance Health Systems UK Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)

10.

Creditors

Creditors: amounts falling due within one year

Note

31.12.24
£

31.12.23
£

Due within one year

 

Trade creditors

 

142,945

198,870

Amounts owed to group undertakings and undertakings in which the company has a participating interest

11

7,477,011

6,519,348

Taxation and social security

 

17,090

21,729

Accruals and deferred income

 

11,000

10,900

Other creditors

 

107,766

316,549

 

7,755,812

7,067,396

11.

Related party transactions

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 ' The Financial Reporting Standard applicable in the UK', not to disclose related party transactions with wholly owned subsidiaries within the group.